Study Description
The objective of this study is to evaluate the long-term safety of Leqvio in patients
with familial hypercholesterolaemia or hypercholesterolaemia in post-marketing clinical
practice Uncontrolled, central registration system, multicenter, special drug use-results
surveillance.
This is a prospective, open-label, multicenter, single-arm observational study
(non-interventional study: NIS) conducted only in Japan.
The survey will include patients with familial hypercholesterolaemia or
hypercholesterolaemia who have received treatment with Leqvio. Patients who discontinued
treatment with Leqvio before completing the 24-month observation period will be followed
for safety until the date of the last dose of Leqvio plus 180 days or until 24 months
after the first dose of Leqvio, whichever comes earlier.
Interventions
inclisiran
Eligibility Criteria
Inclusion Criteria:
- Patients who provided written informed consent to participate in this survey prior
to the start of treatment with Leqvio.
- Patients who received treatment with Leqvio as per the package insert.
Exclusion Criteria:
- Patients who received treatment with a formulation containing the same ingredients
as Leqvio in the past.
- Patients participating in other interventional studies at the time of informed
consent.
- Patients planning to participate in other interventional studies during this survey.
Study Location
Novartis Investigative Site
Recruiting
Tsushima,Aichi,496-0038,Japan
Novartis Investigative Site
Recruiting
Ikoma,Nara,636-0802,Japan
Novartis Investigative Site
Recruiting
Kyoto-city,Kyoto,602-8566,Japan
Novartis Investigative Site
Recruiting
Sapporo,Hokkaido,062-0003,Japan
Novartis Investigative Site
Recruiting
Fukuoka city,Fukuoka,814 0180,Japan
Novartis Investigative Site
Recruiting
Yokosuka,Kanagawa,240-0101,Japan
Novartis Investigative Site
Recruiting
Koga,Ibaraki,306-0232,Japan
Novartis Investigative Site
Recruiting
Nagoya,Aichi,461-0045,Japan
Novartis Investigative Site
Recruiting
Urasoe,Okinawa,901-2102,Japan
Novartis Investigative Site
Recruiting
Kamisu,Ibaraki,314-0146,Japan
Novartis Investigative Site
Recruiting
Matsuyama,Ehime,791-8016,Japan
Novartis Investigative Site
Recruiting
Sapporo,Hokkaido,065-0027,Japan
Novartis Investigative Site
Recruiting
Fukushima city,Fukushima,960 1295,Japan
Novartis Investigative Site
Recruiting
Komaki,Aichi,485-8520,Japan
Novartis Investigative Site
Recruiting
Oita-city,Oita,870-0263,Japan
Novartis Investigative Site
Recruiting
Urayasu,Chiba,279-0021,Japan
Novartis Investigative Site
Recruiting
Kanazawa,Ishikawa,920 8641,Japan
Novartis Investigative Site
Recruiting
Mito,Ibaraki,310-0015,Japan
Novartis Investigative Site
Recruiting
Handa,Aichi,475-0817,Japan
Novartis Investigative Site
Recruiting
Shirakawa,Fukushima,961-0005,Japan
Novartis Investigative Site
Recruiting
Koriyama,Fukushima,963-8501,Japan
Novartis Investigative Site
Recruiting
Amagasaki,Hyogo,660-8511,Japan
Novartis Investigative Site
Recruiting
Okayama-city,Okayama,700-8558,Japan
Novartis Investigative Site
Recruiting
Kashihara,Nara,634-0045,Japan
Novartis Investigative Site
Recruiting
Uruma,Okinawa,904-2293,Japan
Novartis Investigative Site
Recruiting
Miyakonojo,Miyazaki,885-0002,Japan
Novartis Investigative Site
Recruiting
Himeji,Hyogo,670-8560,Japan
Novartis Investigative Site
Recruiting
Takarazuka-city,Hyogo,665-0873,Japan
Novartis Investigative Site
Recruiting
Kurashiki,Okayama,713-8121,Japan
Novartis Investigative Site
Recruiting
Asahikawa,Hokkaido,078-8214,Japan
Novartis Investigative Site
Recruiting
Omura,Nagasaki,856-8562,Japan
Novartis Investigative Site
Recruiting
Kitakyushu-city,Fukuoka,807-8556,Japan
Novartis Investigative Site
Recruiting
Yatsushiro-city,Kumamoto,866-8533,Japan
Novartis Investigative Site
Recruiting
Moriya-city,Ibaraki,302-0102,Japan
Novartis Investigative Site
Recruiting
Ichinomiya,Aichi,491-8551,Japan
Novartis Investigative Site
Recruiting
Toyoake city,Aichi,470 1192,Japan
Novartis Investigative Site
Recruiting
Kure-city,Hiroshima,737-0023,Japan
Novartis Investigative Site
Recruiting
Ono,Hyogo,675-1327,Japan
Novartis Investigative Site
Recruiting
Asahi,Chiba,289-2511,Japan
Novartis Investigative Site
Recruiting
Kitakyushu,Fukuoka,800-0031,Japan
Novartis Investigative Site
Recruiting
Yokohama,Kanagawa,235-0016,Japan
Novartis Investigative Site
Recruiting
Nagaoka,Niigata,940-8621,Japan
Novartis Investigative Site
Recruiting
Ichinomiya,Aichi,494-0001,Japan
Novartis Investigative Site
Recruiting
Tsukuba,Ibaraki,305-8576,Japan
Novartis Investigative Site
Recruiting
Kyotanabe,Kyoto,610-0334,Japan
Novartis Investigative Site
Recruiting
Sapporo,Hokkaido,004-0052,Japan
Novartis Investigative Site
Recruiting
Fujisawa,Kanagawa,252-0802,Japan
Novartis Investigative Site
Recruiting
Kobe,Hyogo,654-0026,Japan
Novartis Investigative Site
Recruiting
Yokosuka,Kanagawa,238-8567,Japan
Novartis Investigative Site
Recruiting
Nagoya,Aichi,454-0933,Japan
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.